Clinical Trial Update: Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Ain Shams University is evaluating whether Coenzyme Q10 can prevent contrast-induced nephropathy in patients with acute co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Coronary Syndrome

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Ain Shams University | Conditions: Contrast-induced Nephropathy | Phase 4 | Status: UNKNOWN